-
2025 CASH丨Dr. Rong Fu: Interpretation of the PNH China Guidelines
The 5th Annual Meeting of Chinese Alliance for Societies of Hematology (2025 CASH) was held in Tianjin from January 3 to 5, under the theme “Comprehensive Hematology, Comprehensive Health, and Comprehensive Well-being.” Top hematology experts from China and abroad were invited to discuss the latest advancements and future trends in hematology.
-
ASH 2024 | Dr. Paul Monagle on Pediatric Deep Vein Thrombosis (VTE): Epidemiology, Updated Guidelines, and Treatment Recommendations
1. Epidemiology and Mechanisms of Pediatric VTE Hematology Frontier: Pediatric deep vein thrombosis (VTE) is relatively rare but shows an increasing trend. Could you elaborate on the epidemiology and underlying…
-
2025 CASH丨Another Milestone! Dr. Jing Pan’s Team Recognized in the Top 10 Hematology Research Advancements of 2024
From January 3–5, 2025, the 5th Annual Meeting of Chinese Alliance for Societies of Hematology (CASH) was held in Tianjin under the theme “Comprehensive Hematology, Comprehensive Health, and Comprehensive Well-being.” As a key highlight of the conference, the Top 10 Hematology Research Advancements of 2024 were announced during the closing ceremony, recognizing significant scientific achievements…
-
Annual Review | Prof. Jun Ma: 2024 Updates on Guidelines and Advances in Acute Lymphoblastic Leukemia (ALL)
In recent years, the field of hematologic oncology has witnessed remarkable breakthroughs, with acute lymphoblastic leukemia (ALL) emerging as a focal point of progress. Chinese researchers have made significant contributions, driving milestone advancements in both research and clinical practice. To usher in the new year, Hematology Frontier invited Professor Jun Ma from the Harbin Institute…
-
Dr. Hongwei Yao: Organ Preservation and Survival in Mid-Low Rectal Cancer with Radiotherapy and PD-1 Inhibitors
Oncology Frontier: Could you explain the unique value of combining long-course radiotherapy with PD-1 inhibitors in neoadjuvant therapy for mid-to-low rectal cancer? What advantages has this treatment strategy shown in…
-
Annual Review | Prof. Shuhua Yi: Highlights of 2024 Advances in Mantle Cell Lymphoma
In recent years, the field of hematologic oncology has experienced remarkable breakthroughs, with significant advancements in mantle cell lymphoma (MCL). Chinese researchers have increasingly contributed to this progress, playing a pivotal role in driving academic development and clinical practice in the field. As we step into the new year, Hematology Frontier invited Professor Shuhua Yi…
-
Dr. Rongbo Lin: Exploring the Clinical Pathology and Molecular Features of New Targets in Gastric Cancer
Advances in Molecular Subtyping of Gastric Cancer As research progresses, gastric cancer studies have transitioned from traditional histological classifications, such as Lauren and WHO classifications, to molecular subtyping, notably the…
-
Annual Review | Dr. Xiuying Xiao’s Team Highlights Advances in Colorectal Cancer Diagnosis and Treatment in 2024
Authors: Yongchao Wang, Ting Han, Xiaolin Lin, Xiuying Xiao I. New Strategies and Modalities in Perioperative Treatment The perioperative treatment of CRC witnessed the emergence of multiple innovative strategies in…
Connecting Medical Expertise through Media